Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation

References

• Charman WN, Porter CJH. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv Drug Deliv Rev. 1996;19:149–169.
   Web of Science ®Google Scholar
• Porter CJH, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 2001;50:61–80.
   PubMed Web of Science ®Google Scholar
• Driscoll MC. Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci. 2002;15:405–415.
   PubMed Web of Science ®Google Scholar
• Müller RH, Mehnert W, Lucks JS. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm. 1995;41:62–69.
   Web of Science ®Google Scholar
• Mehnert W, Mäder K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev. 2001;47:165–196.
   PubMed Web of Science ®Google Scholar
• Kopparam M, Vobalaboina V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Rel. 2005;107:215–228.
   PubMed Web of Science ®Google Scholar
• Narendar D, Kishan V. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2016;23:395–404.
   PubMed Web of Science ®Google Scholar
• Schwarz C. Solid lipid nanoparticles (SLN) for controlled drug delivery II: drug incorporation and physicochemical characterization. J Microencapsul. 1999;16:205–213.
   PubMed Web of Science ®Google Scholar
• Sahu PK, Mishra DK, Jain N, et al. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel. Drug Dev Ind Pharm. 2015;41:640–649.
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 2009;30:226–232.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131–S155.
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 2002;242:121–128.
   PubMed Web of Science ®Google Scholar
• Müller RH, Keck CM. Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles. J Biotechnol. 2004;113:151.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Eskandari S, Tabakhian M. Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design. Pharm Dev Technol. 2010;15:89–96.
   PubMed Web of Science ®Google Scholar
• Jores K, Mehnert W, Drechsler M, et al. Investigations on the structure of solid lipid nanoparticles (SLN) an oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release. 2004;95:217–227.
   PubMed Web of Science ®Google Scholar
• Piyush J, Bina G, Amber V. Nanostructured lipid carriers and their current application in targeted drug delivery. Artif Cells Nanomed Biotechnol. 2016;44:27–40.
   PubMed Web of Science ®Google Scholar
• Hamilton SF, Houle LM, Thadani U. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure. Heart Dis. 1999;5:279–288.
   Google Scholar
• Hitomi T, Ayako O, Hideyasu M, et al. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther. 2000;67:201–214.
   PubMed Web of Science ®Google Scholar
• Narendar D, Kishan V. Pharmacokinetic and pharmacodynamic studies of nisoldipine loaded solid lipid nanoparticles by central composite design. Drug Dev Ind Pharm. 2015;41:1968–1977.
   PubMed Web of Science ®Google Scholar
• Nekkanti V, Rueda J, Wang Z, et al. Comparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipine. Int J Pharm. 2016;505:79–88.
   PubMed Web of Science ®Google Scholar
• Ganesh BP, Nandkishor DP, Prashant KD, et al. Nanostructured lipid carriers as a potential vehicle for Carvedilol delivery: application of factorial design approach. Artif Cells Nanomed Biotechnol. 2016;44:12–19.
   PubMed Web of Science ®Google Scholar
• Zhuang CY, Li N, Wang M, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharma. 2010;394:179–185.
   PubMed Web of Science ®Google Scholar
• Shete H, Chatterjee S, De A, et al. Long chain lipid base tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies. Int J Pharm. 2013;454:584–592.
   PubMed Web of Science ®Google Scholar
• Shete H, Patravale V. Long chain lipid based tamoxifen NLC – part I: preformulation studies, formulation development and physicochemical characterization. Int J Pharm. 2013;454:573–583.
   PubMed Web of Science ®Google Scholar
• Hu FQ, Jiang SP, Du YZ, et al. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 2005;45:167–173.
   PubMed Web of Science ®Google Scholar
• Beloqui A, Solinis MA, Gascon AR, et al. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 2012;166:115–123.
   PubMed Web of Science ®Google Scholar
• Li M, Wang Q, Wang C, et al. Tissues distribution of R-(-)- and S-(+)-m-nisoldipine after single enantiomer administration in rats. Drug Dev Ind Pharm. 2009;35:65–72.
   PubMed Web of Science ®Google Scholar
• Mitri K, Shegokar R, Gohla S, et al. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. Int J Pharm. 2011;414:267–275.
   PubMed Web of Science ®Google Scholar
• Müller BG, Leuenberger H, Kissel T. Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique. Pharm Res. 1996;13:32–37.
   PubMed Web of Science ®Google Scholar
• Zheng K, Zou A, Yang X, et al. The effect of polymer surfactant emulsifying agent on the formation and stability of a-lipoic acid loaded nanostructured lipid carriers (NLC). Food Hydrocoll. 2013;32:72–78.
   Web of Science ®Google Scholar
• Karthik YJ, Raju J, Ashok V, et al. Bioavailability enhancement of zaleplon via proliposomes: role of surface charge. Eur J Pharm Biopharm. 2012;80:347–357.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release. 2004;95:627–638.
   PubMed Web of Science ®Google Scholar
• Zhang T, Chen J, Zhang Y, et al. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci. 2011;43:174–179.
   PubMed Web of Science ®Google Scholar
• Kritika S, Supandeep SH, Bharat L, et al. Development and characterization of floating spheroids of atorvastatin calcium loaded NLC for enhancement of oral bioavailability. Artif Cells Nanomed Biotechnol. 2016;44:1448–1456.
   PubMed Web of Science ®Google Scholar
• Arik D, Amnon H. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm. 2007;67:96–105.
   PubMed Web of Science ®Google Scholar